UEG Week Recordings UEG Week Posters Online courses Guidelines Mistakes in... Podcasts Webinars
new
Gut Guide online
Visit ueg.eu Create myUEG account Log In
Visit ueg.eu Create myUEG account Log In

Filters:

UEG Mistakes In Articles
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Mistakes in chronic intestinal pseudo-obstruction

Carolina Malagelada, Luis Gerardo Alcala Gonzalez

Summary

AI Generated

This article addresses common mistakes in the diagnosis and management of chronic intestinal pseudo-obstruction, a severe condition where the intestines fail to propel contents due to disordered smooth muscle and nerve coordination.

  • Chronic intestinal pseudo-obstruction is a severe condition resulting from disorders in gastrointestinal smooth muscle and nerve function coordination, leading to failure of intestinal propulsion.
  • Management of chronic intestinal pseudo-obstruction involves improving intestinal motility, maintaining nutrition, treating complications, managing exacerbations, and carefully considering invasive procedures.
  • The material focuses on common diagnostic and management mistakes in chronic intestinal pseudo-obstruction, drawing on evidence-based insights and clinical experience.
  • Clinicians managing patients with chronic intestinal pseudo-obstruction or suspected motility disorders would benefit from this content.
Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

References

Mistakes
References
Mistake 1 Mistake 2 Mistake 3 Mistake 4 Mistake 5 Mistake 6 Mistake 7 Mistake 8
1.
Gallego D, Malagelada C, Accarino A, et al. Functional neuromuscular impairment in severe intestinal dysmotility. Neurogastroenterol Motil 2018; 30: e13458. [Link]
2.
Rosen R, Garza JM, Tipnis N, et al. An ANMS-NASPGHAN consensus document on esophageal and antroduodenal manometry in children. Neurogastroenterol Motil 2018; 30: e13239. [Link]
3.
Stanghellini V, Cogliandro RF, De Giorgio R, et al. Natural history of chronic idiopathic intestinal pseudo-obstruction in adults: a single center study. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 2005; 3: 449–458. [Link]
4.
Keller J, Bassotti G, Clarke J, et al. Expert consensus document: Advances in the diagnosis and classification of gastric and intestinal motility disorders. Nat Rev Gastroenterol Hepatol 2018; 15: 291–308. [Link]
5.
Ang D, Pannemans J, Vanuytsel T, et al. A single-center audit of the indications and clinical impact of prolonged ambulatory small intestinal manometry. Neurogastroenterol Motil 2018; 30: e13357. [Link]
6.
Alcalá-González LG, Malagelada C, Monrroy H, et al. Clinical significance of small bowel manometry patterns suggestive of intestinal obstruction. Neurogastroenterol Motil 2023; 35: e14462. [Link]
7.
Alcala-Gonzalez LG, Malagelada C, Galan C, et al. Propagation patterns of jejunal motor activity measured by high-resolution water-perfused manometry. Neurogastroenterol Motil Off J Eur Gastrointest Motil Soc 2021; 33: e14240. [Link]
8.
de Jonge CS, Smout AJPM, Nederveen AJ, et al. Evaluation of gastrointestinal motility with MRI: Advances, challenges and opportunities. Neurogastroenterol Motil 2018; 30: e13257. [Link]
9.
Maurer AH. Enhancing Scintigraphy for Evaluation of Gastric, Small Bowel, and Colonic Motility. Gastroenterol Clin North Am 2020; 49: 499–517. [Link]
10.
Ohkubo H, Kessoku T, Fuyuki A, et al. Assessment of small bowel motility in patients with chronic intestinal pseudo-obstruction using cine-MRI. Am J Gastroenterol 2013; 108: 1130–1139. [Link]
11.
Menys A, Butt S, Emmanuel A, et al. Comparative quantitative assessment of global small bowel motility using magnetic resonance imaging in chronic intestinal pseudo-obstruction and healthy controls. Neurogastroenterol Motil 2016; 28: 376–383. [Link]
12.
Alcalá-González LG, Accarino A, Martí R, et al. Distinctive gastrointestinal motor dysfunction in patients with MNGIE. Neurogastroenterol Motil 2023; 35: e14643. [Link]
13.
Alcalá González LG, Malagelada C. Current insights on chronic intestinal dysmotility: pseudo-obstruction and enteric dysmotility. Rev Esp Enferm Dig 2024; 116: 63–67. [Link]
14.
Di Nardo G, Zenzeri L, Guarino M, et al. Pharmacological and nutritional therapy of children and adults with chronic intestinal pseudo-obstruction. Expert Rev Gastroenterol Hepatol 2023; 17: 325–341. [Link]
15.
Basilisco G, Marchi M, Coletta M. Chronic intestinal pseudo-obstruction in adults: A practical guide to identify patient subgroups that are suitable for more specific treatments. Neurogastroenterol Motil 2024; 36: e14715. [Link]
16.
Bianco F, Lattanzio G, Lorenzini L, et al. Enteric Neuromyopathies: Highlights on Genetic Mechanisms Underlying Chronic Intestinal Pseudo-Obstruction. Biomolecules 2022; 12: 1849. [Link]
17.
Hahn JW, Moon SY, Kim MS, et al. ACTG2 Variants in Pediatric Chronic Intestinal Pseudo-obstruction With Megacystis. J Neurogastroenterol Motil 2022; 28: 104–110. [Link]
18.
Bianco F, Bonora E, Lattanzio G, et al. Clinical and Pathological Features of Severe Gut Dysmotility. Adv Exp Med Biol 2022; 1383: 9–17. [Link]
19.
D’Angelo R, Boschetti E, Amore G, et al. Liver transplantation in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical long-term follow-up and pathogenic implications. J Neurol 2020; 267: 3702–3710. [Link]
20.
Stanghellini V, Cogliandro RF, de Giorgio R, et al. Chronic intestinal pseudo-obstruction: manifestations, natural history and management. Neurogastroenterol Motil 2007; 19: 440–452. [Link]
21.
Knowles CH, Veress B, Tornblom H, et al. Safety and diagnostic yield of laparoscopically assisted full-thickness bowel biospy. Neurogastroenterol Motil 2008; 20: 774–779. [Link]
22.
Malagelada C, Karunaratne TB, Accarino A, et al. Comparison between small bowel manometric patterns and full-thickness biopsy histopathology in severe intestinal dysmotility. Neurogastroenterol Motil 2018; 30: e13219. [Link]
23.
De Giorgio R, Bianco F, Latorre R, et al. Enteric neuropathies: Yesterday, Today and Tomorrow. Adv Exp Med Biol 2016; 891: 123–133. [Link]
24.
De Giorgio R, Barbara G, Stanghellini V, et al. Clinical and morphofunctional features of idiopathic myenteric ganglionitis underlying severe intestinal motor dysfunction: a study of three cases. Am J Gastroenterol 2002; 97: 2454–2459. [Link]
25.
Rossi S, Merli E, Rinaldi R, et al. Paraneoplastic vs. non-paraneoplastic anti-Hu associated dysmotility: a case series and literature review. J Neurol 2022; 269: 1182–1194. [Link]
26.
Di Nardo G, Di Lorenzo C, Lauro A, et al. Chronic intestinal pseudo-obstruction in children and adults: diagnosis and therapeutic options. Neurogastroenterol Motil 2017; 29: e12945. [Link]
27.
Radocchia G, Neroni B, Marazzato M, et al. Chronic Intestinal Pseudo-Obstruction: Is There a Connection with Gut Microbiota? Microorganisms 2021; 9: 2549. [Link]
28.
Bor S, Kalkan İH, Savarino E, et al. Prokinetics-safety and efficacy: The European Society of Neurogastroenterology and Motility/The American Neurogastroenterology and Motility Society expert review. Neurogastroenterol Motil 2024; 36: e14774. [Link]
29.
Ohkubo H, Fuyuki A, Arimoto J, et al. Efficacy of percutaneous endoscopic gastro-jejunostomy (PEG-J) decompression therapy for patients with chronic intestinal pseudo-obstruction (CIPO). Neurogastroenterol Motil 2017; 29: e13127. [Link]
30.
Mann SD, Debinski HS, Kamm MA. Clinical characteristics of chronic idiopathic intestinal pseudo-obstruction in adults. Gut 1997; 41: 675–681. [Link]
31.
Emmanuel AV, Shand AG, Kamm MA. Erythromycin for the treatment of chronic intestinal pseudo-obstruction: description of six cases with a positive response. Aliment Pharmacol Ther 2004; 19: 687–694. [Link]
32.
O’Dea CJ, Brookes JH, Wattchow DA. The efficacy of treatment of patients with severe constipation or recurrent pseudo-obstruction with pyridostigmine. Colorectal Dis Off J Assoc Coloproctology G B Irel 2010; 12: 540–548. [Link]
33.
Sabbagh C, Amiot A, Maggiori L, et al. Non-transplantation surgical approach for chronic intestinal pseudo-obstruction: analysis of 63 adult consecutive cases. Neurogastroenterol Motil 2013; 25: e680-686. [Link]
34.
Sogawa H, Costa G, Armanyous S, et al. Twenty Years of Gut Transplantation for Chronic Intestinal Pseudo-obstruction: Technical Innovation, Long-term Outcome, Quality of Life, and Disease Recurrence. Ann Surg 2021; 273: 325–333. [Link]

Abstract

The coordination of smooth muscle and nerve function in the gastrointestinal tract is crucial for digestion and waste disposal. Disorders in this process can lead to chronic intestinal pseudo-obstruction (CIPO), a severe condition where the intestines fail to propel contents. Managing CIPO involves improving intestinal motility, maintaining nutrition, treating complications, managing exacerbations, and carefully considering invasive procedures. This article focuses on common mistakes in CIPO diagnosis and management, offering evidence-based insights and clinical experience.

Topics

Neurogastroenterology & Motility

Citation

Malagelada C and Alcalá-González LG. Mistakes in chronic intestinal pseudo obstruction and how to avoid them. UEG Education 2024; 24: 12-17.

Published

2024

More Like This:

MASLD with Sven Francque - Part 2

MASLD with Sven Francque - Part 2

Pradeep Mundre Pradeep Mundre, Sven Francque

Mistakes in the management of peritoneal malignancies and how to avoid them

Mistakes in the management of peritoneal malignancies and how to avoid them

Charlotte Rabl Charlotte Rabl, Tarkan Jäger, Andrea Barberis, Matteo Santoliquido, Francesco Saverio Papadia

Mistakes in ostomy management and how to avoid them

Mistakes in ostomy management and how to avoid them

Ian White Ian White, Iris Dotan, Revital Barkan

Mistakes in coeliac disease diagnosis and how to avoid them

Mistakes in coeliac disease diagnosis and how to avoid them

Roberto De Giorgio Roberto De Giorgio, Giacomo Caio, Umberto Volta

Mistakes in the management of carbohydrate intolerance and how to avoid them

Mistakes in the management of carbohydrate intolerance and how to avoid them

Johann Hammer Johann Hammer, Heinz Florian Hammer, Mark Fox

Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update

Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update

Andrew Veitch Andrew Veitch

UEG Podcast Episode
UEG Podcast
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

MASLD with Sven Francque - Part 2

Sven Francque, Pradeep Mundre

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Topics

Hepatobiliary

Published

2026

More Like This:

MASLD with Sven Francque - Part 2

MASLD with Sven Francque - Part 2

Pradeep Mundre Pradeep Mundre, Sven Francque

Mistakes in the management of peritoneal malignancies and how to avoid them

Mistakes in the management of peritoneal malignancies and how to avoid them

Charlotte Rabl Charlotte Rabl, Tarkan Jäger, Andrea Barberis, Matteo Santoliquido, Francesco Saverio Papadia

Mistakes in ostomy management and how to avoid them

Mistakes in ostomy management and how to avoid them

Ian White Ian White, Iris Dotan, Revital Barkan

Mistakes in coeliac disease diagnosis and how to avoid them

Mistakes in coeliac disease diagnosis and how to avoid them

Roberto De Giorgio Roberto De Giorgio, Giacomo Caio, Umberto Volta

Mistakes in the management of carbohydrate intolerance and how to avoid them

Mistakes in the management of carbohydrate intolerance and how to avoid them

Johann Hammer Johann Hammer, Heinz Florian Hammer, Mark Fox

Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update

Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update

Andrew Veitch Andrew Veitch

UEG Mistakes In Articles
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Mistakes in the management of peritoneal malignancies and how to avoid them

Francesco Saverio Papadia, Matteo Santoliquido, Andrea Barberis, Tarkan Jäger, Charlotte Rabl

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

References

Mistakes
References
Mistake 1 Mistake 2 Mistake 3 Mistake 4 Mistake 5 Mistake 6 Mistake 7 Mistake 8
1.
Gallego D, Malagelada C, Accarino A, et al. Functional neuromuscular impairment in severe intestinal dysmotility. Neurogastroenterol Motil 2018; 30: e13458. [Link]
2.
Rosen R, Garza JM, Tipnis N, et al. An ANMS-NASPGHAN consensus document on esophageal and antroduodenal manometry in children. Neurogastroenterol Motil 2018; 30: e13239. [Link]
3.
Stanghellini V, Cogliandro RF, De Giorgio R, et al. Natural history of chronic idiopathic intestinal pseudo-obstruction in adults: a single center study. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 2005; 3: 449–458. [Link]
4.
Keller J, Bassotti G, Clarke J, et al. Expert consensus document: Advances in the diagnosis and classification of gastric and intestinal motility disorders. Nat Rev Gastroenterol Hepatol 2018; 15: 291–308. [Link]
5.
Ang D, Pannemans J, Vanuytsel T, et al. A single-center audit of the indications and clinical impact of prolonged ambulatory small intestinal manometry. Neurogastroenterol Motil 2018; 30: e13357. [Link]
6.
Alcalá-González LG, Malagelada C, Monrroy H, et al. Clinical significance of small bowel manometry patterns suggestive of intestinal obstruction. Neurogastroenterol Motil 2023; 35: e14462. [Link]
7.
Alcala-Gonzalez LG, Malagelada C, Galan C, et al. Propagation patterns of jejunal motor activity measured by high-resolution water-perfused manometry. Neurogastroenterol Motil Off J Eur Gastrointest Motil Soc 2021; 33: e14240. [Link]
8.
de Jonge CS, Smout AJPM, Nederveen AJ, et al. Evaluation of gastrointestinal motility with MRI: Advances, challenges and opportunities. Neurogastroenterol Motil 2018; 30: e13257. [Link]
9.
Maurer AH. Enhancing Scintigraphy for Evaluation of Gastric, Small Bowel, and Colonic Motility. Gastroenterol Clin North Am 2020; 49: 499–517. [Link]
10.
Ohkubo H, Kessoku T, Fuyuki A, et al. Assessment of small bowel motility in patients with chronic intestinal pseudo-obstruction using cine-MRI. Am J Gastroenterol 2013; 108: 1130–1139. [Link]
11.
Menys A, Butt S, Emmanuel A, et al. Comparative quantitative assessment of global small bowel motility using magnetic resonance imaging in chronic intestinal pseudo-obstruction and healthy controls. Neurogastroenterol Motil 2016; 28: 376–383. [Link]
12.
Alcalá-González LG, Accarino A, Martí R, et al. Distinctive gastrointestinal motor dysfunction in patients with MNGIE. Neurogastroenterol Motil 2023; 35: e14643. [Link]
13.
Alcalá González LG, Malagelada C. Current insights on chronic intestinal dysmotility: pseudo-obstruction and enteric dysmotility. Rev Esp Enferm Dig 2024; 116: 63–67. [Link]
14.
Di Nardo G, Zenzeri L, Guarino M, et al. Pharmacological and nutritional therapy of children and adults with chronic intestinal pseudo-obstruction. Expert Rev Gastroenterol Hepatol 2023; 17: 325–341. [Link]
15.
Basilisco G, Marchi M, Coletta M. Chronic intestinal pseudo-obstruction in adults: A practical guide to identify patient subgroups that are suitable for more specific treatments. Neurogastroenterol Motil 2024; 36: e14715. [Link]
16.
Bianco F, Lattanzio G, Lorenzini L, et al. Enteric Neuromyopathies: Highlights on Genetic Mechanisms Underlying Chronic Intestinal Pseudo-Obstruction. Biomolecules 2022; 12: 1849. [Link]
17.
Hahn JW, Moon SY, Kim MS, et al. ACTG2 Variants in Pediatric Chronic Intestinal Pseudo-obstruction With Megacystis. J Neurogastroenterol Motil 2022; 28: 104–110. [Link]
18.
Bianco F, Bonora E, Lattanzio G, et al. Clinical and Pathological Features of Severe Gut Dysmotility. Adv Exp Med Biol 2022; 1383: 9–17. [Link]
19.
D’Angelo R, Boschetti E, Amore G, et al. Liver transplantation in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical long-term follow-up and pathogenic implications. J Neurol 2020; 267: 3702–3710. [Link]
20.
Stanghellini V, Cogliandro RF, de Giorgio R, et al. Chronic intestinal pseudo-obstruction: manifestations, natural history and management. Neurogastroenterol Motil 2007; 19: 440–452. [Link]
21.
Knowles CH, Veress B, Tornblom H, et al. Safety and diagnostic yield of laparoscopically assisted full-thickness bowel biospy. Neurogastroenterol Motil 2008; 20: 774–779. [Link]
22.
Malagelada C, Karunaratne TB, Accarino A, et al. Comparison between small bowel manometric patterns and full-thickness biopsy histopathology in severe intestinal dysmotility. Neurogastroenterol Motil 2018; 30: e13219. [Link]
23.
De Giorgio R, Bianco F, Latorre R, et al. Enteric neuropathies: Yesterday, Today and Tomorrow. Adv Exp Med Biol 2016; 891: 123–133. [Link]
24.
De Giorgio R, Barbara G, Stanghellini V, et al. Clinical and morphofunctional features of idiopathic myenteric ganglionitis underlying severe intestinal motor dysfunction: a study of three cases. Am J Gastroenterol 2002; 97: 2454–2459. [Link]
25.
Rossi S, Merli E, Rinaldi R, et al. Paraneoplastic vs. non-paraneoplastic anti-Hu associated dysmotility: a case series and literature review. J Neurol 2022; 269: 1182–1194. [Link]
26.
Di Nardo G, Di Lorenzo C, Lauro A, et al. Chronic intestinal pseudo-obstruction in children and adults: diagnosis and therapeutic options. Neurogastroenterol Motil 2017; 29: e12945. [Link]
27.
Radocchia G, Neroni B, Marazzato M, et al. Chronic Intestinal Pseudo-Obstruction: Is There a Connection with Gut Microbiota? Microorganisms 2021; 9: 2549. [Link]
28.
Bor S, Kalkan İH, Savarino E, et al. Prokinetics-safety and efficacy: The European Society of Neurogastroenterology and Motility/The American Neurogastroenterology and Motility Society expert review. Neurogastroenterol Motil 2024; 36: e14774. [Link]
29.
Ohkubo H, Fuyuki A, Arimoto J, et al. Efficacy of percutaneous endoscopic gastro-jejunostomy (PEG-J) decompression therapy for patients with chronic intestinal pseudo-obstruction (CIPO). Neurogastroenterol Motil 2017; 29: e13127. [Link]
30.
Mann SD, Debinski HS, Kamm MA. Clinical characteristics of chronic idiopathic intestinal pseudo-obstruction in adults. Gut 1997; 41: 675–681. [Link]
31.
Emmanuel AV, Shand AG, Kamm MA. Erythromycin for the treatment of chronic intestinal pseudo-obstruction: description of six cases with a positive response. Aliment Pharmacol Ther 2004; 19: 687–694. [Link]
32.
O’Dea CJ, Brookes JH, Wattchow DA. The efficacy of treatment of patients with severe constipation or recurrent pseudo-obstruction with pyridostigmine. Colorectal Dis Off J Assoc Coloproctology G B Irel 2010; 12: 540–548. [Link]
33.
Sabbagh C, Amiot A, Maggiori L, et al. Non-transplantation surgical approach for chronic intestinal pseudo-obstruction: analysis of 63 adult consecutive cases. Neurogastroenterol Motil 2013; 25: e680-686. [Link]
34.
Sogawa H, Costa G, Armanyous S, et al. Twenty Years of Gut Transplantation for Chronic Intestinal Pseudo-obstruction: Technical Innovation, Long-term Outcome, Quality of Life, and Disease Recurrence. Ann Surg 2021; 273: 325–333. [Link]

Abstract

Peritoneal malignancies represent a complex and often misjudged clinical challenge. Historically synonymous with a terminal diagnosis, the advent of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) radically altered the prognosis for selected patients. However, progress has been jeopardised by a series of recurring and preventable errors in diagnosis, staging, and treatment selection. This article delineates the ten most critical pitfalls in managing peritoneal surface malignancies. For each pitfall, we provide evidence-based explanations, concrete clinical examples, and strategic recommendations for avoidance. We emphasise the pivotal role of early multidisciplinary discussion, precise imaging, and timely referral to high-volume expert centres to optimise patient outcomes and offer curative intent where previously there was none.

Topics

Digestive Oncology Surgery

Published

2026

More Like This:

MASLD with Sven Francque - Part 2

MASLD with Sven Francque - Part 2

Pradeep Mundre Pradeep Mundre, Sven Francque

Mistakes in the management of peritoneal malignancies and how to avoid them

Mistakes in the management of peritoneal malignancies and how to avoid them

Charlotte Rabl Charlotte Rabl, Tarkan Jäger, Andrea Barberis, Matteo Santoliquido, Francesco Saverio Papadia

Mistakes in ostomy management and how to avoid them

Mistakes in ostomy management and how to avoid them

Ian White Ian White, Iris Dotan, Revital Barkan

Mistakes in coeliac disease diagnosis and how to avoid them

Mistakes in coeliac disease diagnosis and how to avoid them

Roberto De Giorgio Roberto De Giorgio, Giacomo Caio, Umberto Volta

Mistakes in the management of carbohydrate intolerance and how to avoid them

Mistakes in the management of carbohydrate intolerance and how to avoid them

Johann Hammer Johann Hammer, Heinz Florian Hammer, Mark Fox

Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update

Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update

Andrew Veitch Andrew Veitch

UEG Mistakes In Articles
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Mistakes in ostomy management and how to avoid them

Revital Barkan, Ian White, Iris Dotan

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

References

Mistakes
References
Mistake 1 Mistake 2 Mistake 3 Mistake 4 Mistake 5 Mistake 6 Mistake 7 Mistake 8
1.
Gallego D, Malagelada C, Accarino A, et al. Functional neuromuscular impairment in severe intestinal dysmotility. Neurogastroenterol Motil 2018; 30: e13458. [Link]
2.
Rosen R, Garza JM, Tipnis N, et al. An ANMS-NASPGHAN consensus document on esophageal and antroduodenal manometry in children. Neurogastroenterol Motil 2018; 30: e13239. [Link]
3.
Stanghellini V, Cogliandro RF, De Giorgio R, et al. Natural history of chronic idiopathic intestinal pseudo-obstruction in adults: a single center study. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 2005; 3: 449–458. [Link]
4.
Keller J, Bassotti G, Clarke J, et al. Expert consensus document: Advances in the diagnosis and classification of gastric and intestinal motility disorders. Nat Rev Gastroenterol Hepatol 2018; 15: 291–308. [Link]
5.
Ang D, Pannemans J, Vanuytsel T, et al. A single-center audit of the indications and clinical impact of prolonged ambulatory small intestinal manometry. Neurogastroenterol Motil 2018; 30: e13357. [Link]
6.
Alcalá-González LG, Malagelada C, Monrroy H, et al. Clinical significance of small bowel manometry patterns suggestive of intestinal obstruction. Neurogastroenterol Motil 2023; 35: e14462. [Link]
7.
Alcala-Gonzalez LG, Malagelada C, Galan C, et al. Propagation patterns of jejunal motor activity measured by high-resolution water-perfused manometry. Neurogastroenterol Motil Off J Eur Gastrointest Motil Soc 2021; 33: e14240. [Link]
8.
de Jonge CS, Smout AJPM, Nederveen AJ, et al. Evaluation of gastrointestinal motility with MRI: Advances, challenges and opportunities. Neurogastroenterol Motil 2018; 30: e13257. [Link]
9.
Maurer AH. Enhancing Scintigraphy for Evaluation of Gastric, Small Bowel, and Colonic Motility. Gastroenterol Clin North Am 2020; 49: 499–517. [Link]
10.
Ohkubo H, Kessoku T, Fuyuki A, et al. Assessment of small bowel motility in patients with chronic intestinal pseudo-obstruction using cine-MRI. Am J Gastroenterol 2013; 108: 1130–1139. [Link]
11.
Menys A, Butt S, Emmanuel A, et al. Comparative quantitative assessment of global small bowel motility using magnetic resonance imaging in chronic intestinal pseudo-obstruction and healthy controls. Neurogastroenterol Motil 2016; 28: 376–383. [Link]
12.
Alcalá-González LG, Accarino A, Martí R, et al. Distinctive gastrointestinal motor dysfunction in patients with MNGIE. Neurogastroenterol Motil 2023; 35: e14643. [Link]
13.
Alcalá González LG, Malagelada C. Current insights on chronic intestinal dysmotility: pseudo-obstruction and enteric dysmotility. Rev Esp Enferm Dig 2024; 116: 63–67. [Link]
14.
Di Nardo G, Zenzeri L, Guarino M, et al. Pharmacological and nutritional therapy of children and adults with chronic intestinal pseudo-obstruction. Expert Rev Gastroenterol Hepatol 2023; 17: 325–341. [Link]
15.
Basilisco G, Marchi M, Coletta M. Chronic intestinal pseudo-obstruction in adults: A practical guide to identify patient subgroups that are suitable for more specific treatments. Neurogastroenterol Motil 2024; 36: e14715. [Link]
16.
Bianco F, Lattanzio G, Lorenzini L, et al. Enteric Neuromyopathies: Highlights on Genetic Mechanisms Underlying Chronic Intestinal Pseudo-Obstruction. Biomolecules 2022; 12: 1849. [Link]
17.
Hahn JW, Moon SY, Kim MS, et al. ACTG2 Variants in Pediatric Chronic Intestinal Pseudo-obstruction With Megacystis. J Neurogastroenterol Motil 2022; 28: 104–110. [Link]
18.
Bianco F, Bonora E, Lattanzio G, et al. Clinical and Pathological Features of Severe Gut Dysmotility. Adv Exp Med Biol 2022; 1383: 9–17. [Link]
19.
D’Angelo R, Boschetti E, Amore G, et al. Liver transplantation in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical long-term follow-up and pathogenic implications. J Neurol 2020; 267: 3702–3710. [Link]
20.
Stanghellini V, Cogliandro RF, de Giorgio R, et al. Chronic intestinal pseudo-obstruction: manifestations, natural history and management. Neurogastroenterol Motil 2007; 19: 440–452. [Link]
21.
Knowles CH, Veress B, Tornblom H, et al. Safety and diagnostic yield of laparoscopically assisted full-thickness bowel biospy. Neurogastroenterol Motil 2008; 20: 774–779. [Link]
22.
Malagelada C, Karunaratne TB, Accarino A, et al. Comparison between small bowel manometric patterns and full-thickness biopsy histopathology in severe intestinal dysmotility. Neurogastroenterol Motil 2018; 30: e13219. [Link]
23.
De Giorgio R, Bianco F, Latorre R, et al. Enteric neuropathies: Yesterday, Today and Tomorrow. Adv Exp Med Biol 2016; 891: 123–133. [Link]
24.
De Giorgio R, Barbara G, Stanghellini V, et al. Clinical and morphofunctional features of idiopathic myenteric ganglionitis underlying severe intestinal motor dysfunction: a study of three cases. Am J Gastroenterol 2002; 97: 2454–2459. [Link]
25.
Rossi S, Merli E, Rinaldi R, et al. Paraneoplastic vs. non-paraneoplastic anti-Hu associated dysmotility: a case series and literature review. J Neurol 2022; 269: 1182–1194. [Link]
26.
Di Nardo G, Di Lorenzo C, Lauro A, et al. Chronic intestinal pseudo-obstruction in children and adults: diagnosis and therapeutic options. Neurogastroenterol Motil 2017; 29: e12945. [Link]
27.
Radocchia G, Neroni B, Marazzato M, et al. Chronic Intestinal Pseudo-Obstruction: Is There a Connection with Gut Microbiota? Microorganisms 2021; 9: 2549. [Link]
28.
Bor S, Kalkan İH, Savarino E, et al. Prokinetics-safety and efficacy: The European Society of Neurogastroenterology and Motility/The American Neurogastroenterology and Motility Society expert review. Neurogastroenterol Motil 2024; 36: e14774. [Link]
29.
Ohkubo H, Fuyuki A, Arimoto J, et al. Efficacy of percutaneous endoscopic gastro-jejunostomy (PEG-J) decompression therapy for patients with chronic intestinal pseudo-obstruction (CIPO). Neurogastroenterol Motil 2017; 29: e13127. [Link]
30.
Mann SD, Debinski HS, Kamm MA. Clinical characteristics of chronic idiopathic intestinal pseudo-obstruction in adults. Gut 1997; 41: 675–681. [Link]
31.
Emmanuel AV, Shand AG, Kamm MA. Erythromycin for the treatment of chronic intestinal pseudo-obstruction: description of six cases with a positive response. Aliment Pharmacol Ther 2004; 19: 687–694. [Link]
32.
O’Dea CJ, Brookes JH, Wattchow DA. The efficacy of treatment of patients with severe constipation or recurrent pseudo-obstruction with pyridostigmine. Colorectal Dis Off J Assoc Coloproctology G B Irel 2010; 12: 540–548. [Link]
33.
Sabbagh C, Amiot A, Maggiori L, et al. Non-transplantation surgical approach for chronic intestinal pseudo-obstruction: analysis of 63 adult consecutive cases. Neurogastroenterol Motil 2013; 25: e680-686. [Link]
34.
Sogawa H, Costa G, Armanyous S, et al. Twenty Years of Gut Transplantation for Chronic Intestinal Pseudo-obstruction: Technical Innovation, Long-term Outcome, Quality of Life, and Disease Recurrence. Ann Surg 2021; 273: 325–333. [Link]

Abstract

Ostomy management refers to the care and maintenance of an ostomy and involves various aspects to ensure the individual’s health, comfort, and quality of life. This should involve the patient, a close support system (family and/or friends), and a healthcare team, including ostomy nurses and healthcare professionals specialising in ostomy care.

Topics

Primary Care

Published

2025

More Like This:

MASLD with Sven Francque - Part 2

MASLD with Sven Francque - Part 2

Pradeep Mundre Pradeep Mundre, Sven Francque

Mistakes in the management of peritoneal malignancies and how to avoid them

Mistakes in the management of peritoneal malignancies and how to avoid them

Charlotte Rabl Charlotte Rabl, Tarkan Jäger, Andrea Barberis, Matteo Santoliquido, Francesco Saverio Papadia

Mistakes in ostomy management and how to avoid them

Mistakes in ostomy management and how to avoid them

Ian White Ian White, Iris Dotan, Revital Barkan

Mistakes in coeliac disease diagnosis and how to avoid them

Mistakes in coeliac disease diagnosis and how to avoid them

Roberto De Giorgio Roberto De Giorgio, Giacomo Caio, Umberto Volta

Mistakes in the management of carbohydrate intolerance and how to avoid them

Mistakes in the management of carbohydrate intolerance and how to avoid them

Johann Hammer Johann Hammer, Heinz Florian Hammer, Mark Fox

Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update

Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update

Andrew Veitch Andrew Veitch

UEG Mistakes In Articles
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Mistakes in coeliac disease diagnosis and how to avoid them

Roberto De Giorgio 1, Giacomo Caio 1, Umberto Volta 1

Affiliations

1 University of Bologna, Italy

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

References

Mistakes
References
Mistake 1 Mistake 2 Mistake 3 Mistake 4 Mistake 5 Mistake 6 Mistake 7 Mistake 8
1.
Gallego D, Malagelada C, Accarino A, et al. Functional neuromuscular impairment in severe intestinal dysmotility. Neurogastroenterol Motil 2018; 30: e13458. [Link]
2.
Rosen R, Garza JM, Tipnis N, et al. An ANMS-NASPGHAN consensus document on esophageal and antroduodenal manometry in children. Neurogastroenterol Motil 2018; 30: e13239. [Link]
3.
Stanghellini V, Cogliandro RF, De Giorgio R, et al. Natural history of chronic idiopathic intestinal pseudo-obstruction in adults: a single center study. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 2005; 3: 449–458. [Link]
4.
Keller J, Bassotti G, Clarke J, et al. Expert consensus document: Advances in the diagnosis and classification of gastric and intestinal motility disorders. Nat Rev Gastroenterol Hepatol 2018; 15: 291–308. [Link]
5.
Ang D, Pannemans J, Vanuytsel T, et al. A single-center audit of the indications and clinical impact of prolonged ambulatory small intestinal manometry. Neurogastroenterol Motil 2018; 30: e13357. [Link]
6.
Alcalá-González LG, Malagelada C, Monrroy H, et al. Clinical significance of small bowel manometry patterns suggestive of intestinal obstruction. Neurogastroenterol Motil 2023; 35: e14462. [Link]
7.
Alcala-Gonzalez LG, Malagelada C, Galan C, et al. Propagation patterns of jejunal motor activity measured by high-resolution water-perfused manometry. Neurogastroenterol Motil Off J Eur Gastrointest Motil Soc 2021; 33: e14240. [Link]
8.
de Jonge CS, Smout AJPM, Nederveen AJ, et al. Evaluation of gastrointestinal motility with MRI: Advances, challenges and opportunities. Neurogastroenterol Motil 2018; 30: e13257. [Link]
9.
Maurer AH. Enhancing Scintigraphy for Evaluation of Gastric, Small Bowel, and Colonic Motility. Gastroenterol Clin North Am 2020; 49: 499–517. [Link]
10.
Ohkubo H, Kessoku T, Fuyuki A, et al. Assessment of small bowel motility in patients with chronic intestinal pseudo-obstruction using cine-MRI. Am J Gastroenterol 2013; 108: 1130–1139. [Link]
11.
Menys A, Butt S, Emmanuel A, et al. Comparative quantitative assessment of global small bowel motility using magnetic resonance imaging in chronic intestinal pseudo-obstruction and healthy controls. Neurogastroenterol Motil 2016; 28: 376–383. [Link]
12.
Alcalá-González LG, Accarino A, Martí R, et al. Distinctive gastrointestinal motor dysfunction in patients with MNGIE. Neurogastroenterol Motil 2023; 35: e14643. [Link]
13.
Alcalá González LG, Malagelada C. Current insights on chronic intestinal dysmotility: pseudo-obstruction and enteric dysmotility. Rev Esp Enferm Dig 2024; 116: 63–67. [Link]
14.
Di Nardo G, Zenzeri L, Guarino M, et al. Pharmacological and nutritional therapy of children and adults with chronic intestinal pseudo-obstruction. Expert Rev Gastroenterol Hepatol 2023; 17: 325–341. [Link]
15.
Basilisco G, Marchi M, Coletta M. Chronic intestinal pseudo-obstruction in adults: A practical guide to identify patient subgroups that are suitable for more specific treatments. Neurogastroenterol Motil 2024; 36: e14715. [Link]
16.
Bianco F, Lattanzio G, Lorenzini L, et al. Enteric Neuromyopathies: Highlights on Genetic Mechanisms Underlying Chronic Intestinal Pseudo-Obstruction. Biomolecules 2022; 12: 1849. [Link]
17.
Hahn JW, Moon SY, Kim MS, et al. ACTG2 Variants in Pediatric Chronic Intestinal Pseudo-obstruction With Megacystis. J Neurogastroenterol Motil 2022; 28: 104–110. [Link]
18.
Bianco F, Bonora E, Lattanzio G, et al. Clinical and Pathological Features of Severe Gut Dysmotility. Adv Exp Med Biol 2022; 1383: 9–17. [Link]
19.
D’Angelo R, Boschetti E, Amore G, et al. Liver transplantation in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical long-term follow-up and pathogenic implications. J Neurol 2020; 267: 3702–3710. [Link]
20.
Stanghellini V, Cogliandro RF, de Giorgio R, et al. Chronic intestinal pseudo-obstruction: manifestations, natural history and management. Neurogastroenterol Motil 2007; 19: 440–452. [Link]
21.
Knowles CH, Veress B, Tornblom H, et al. Safety and diagnostic yield of laparoscopically assisted full-thickness bowel biospy. Neurogastroenterol Motil 2008; 20: 774–779. [Link]
22.
Malagelada C, Karunaratne TB, Accarino A, et al. Comparison between small bowel manometric patterns and full-thickness biopsy histopathology in severe intestinal dysmotility. Neurogastroenterol Motil 2018; 30: e13219. [Link]
23.
De Giorgio R, Bianco F, Latorre R, et al. Enteric neuropathies: Yesterday, Today and Tomorrow. Adv Exp Med Biol 2016; 891: 123–133. [Link]
24.
De Giorgio R, Barbara G, Stanghellini V, et al. Clinical and morphofunctional features of idiopathic myenteric ganglionitis underlying severe intestinal motor dysfunction: a study of three cases. Am J Gastroenterol 2002; 97: 2454–2459. [Link]
25.
Rossi S, Merli E, Rinaldi R, et al. Paraneoplastic vs. non-paraneoplastic anti-Hu associated dysmotility: a case series and literature review. J Neurol 2022; 269: 1182–1194. [Link]
26.
Di Nardo G, Di Lorenzo C, Lauro A, et al. Chronic intestinal pseudo-obstruction in children and adults: diagnosis and therapeutic options. Neurogastroenterol Motil 2017; 29: e12945. [Link]
27.
Radocchia G, Neroni B, Marazzato M, et al. Chronic Intestinal Pseudo-Obstruction: Is There a Connection with Gut Microbiota? Microorganisms 2021; 9: 2549. [Link]
28.
Bor S, Kalkan İH, Savarino E, et al. Prokinetics-safety and efficacy: The European Society of Neurogastroenterology and Motility/The American Neurogastroenterology and Motility Society expert review. Neurogastroenterol Motil 2024; 36: e14774. [Link]
29.
Ohkubo H, Fuyuki A, Arimoto J, et al. Efficacy of percutaneous endoscopic gastro-jejunostomy (PEG-J) decompression therapy for patients with chronic intestinal pseudo-obstruction (CIPO). Neurogastroenterol Motil 2017; 29: e13127. [Link]
30.
Mann SD, Debinski HS, Kamm MA. Clinical characteristics of chronic idiopathic intestinal pseudo-obstruction in adults. Gut 1997; 41: 675–681. [Link]
31.
Emmanuel AV, Shand AG, Kamm MA. Erythromycin for the treatment of chronic intestinal pseudo-obstruction: description of six cases with a positive response. Aliment Pharmacol Ther 2004; 19: 687–694. [Link]
32.
O’Dea CJ, Brookes JH, Wattchow DA. The efficacy of treatment of patients with severe constipation or recurrent pseudo-obstruction with pyridostigmine. Colorectal Dis Off J Assoc Coloproctology G B Irel 2010; 12: 540–548. [Link]
33.
Sabbagh C, Amiot A, Maggiori L, et al. Non-transplantation surgical approach for chronic intestinal pseudo-obstruction: analysis of 63 adult consecutive cases. Neurogastroenterol Motil 2013; 25: e680-686. [Link]
34.
Sogawa H, Costa G, Armanyous S, et al. Twenty Years of Gut Transplantation for Chronic Intestinal Pseudo-obstruction: Technical Innovation, Long-term Outcome, Quality of Life, and Disease Recurrence. Ann Surg 2021; 273: 325–333. [Link]

Abstract

Coeliac disease is an autoimmune disorder triggered by gluten, which activates an immune reaction against the autoantigen tissue transglutaminase (TG2) in genetically predisposed subjects. Genetic susceptibility to coeliac disease has been proven by its close linkage with major histocompatibility complex (MHC) class II human leukocyte antigen (HLA) DQ2 and DQ8 haplotypes. The identification of biomarkers for coeliac disease (e.g. endomysial antibodies [EmA] and antibodies to TG2 [anti-TG2]) has changed the epidemiology of coeliac disease from being a rare to a frequent condition, with an expected prevalence of 1% in the worldwide population. Coeliac disease can be difficult to diagnose because symptoms vary from patient to patient, and the majority of patients who have coeliac disease remain undiagnosed. Small intestinal biopsy remains the gold standard for coeliac disease diagnosis, and a delayed diagnosis in the elderly can be considered a risk factor for complications. Complicated coeliac disease is not so frequent, but for those who have it, the prognosis is very poor, with a low rate of survival after 5 years.

Topics

Small Intestine & Nutrition

Published

2024

More Like This:

MASLD with Sven Francque - Part 2

MASLD with Sven Francque - Part 2

Pradeep Mundre Pradeep Mundre, Sven Francque

Mistakes in the management of peritoneal malignancies and how to avoid them

Mistakes in the management of peritoneal malignancies and how to avoid them

Charlotte Rabl Charlotte Rabl, Tarkan Jäger, Andrea Barberis, Matteo Santoliquido, Francesco Saverio Papadia

Mistakes in ostomy management and how to avoid them

Mistakes in ostomy management and how to avoid them

Ian White Ian White, Iris Dotan, Revital Barkan

Mistakes in coeliac disease diagnosis and how to avoid them

Mistakes in coeliac disease diagnosis and how to avoid them

Roberto De Giorgio Roberto De Giorgio, Giacomo Caio, Umberto Volta

Mistakes in the management of carbohydrate intolerance and how to avoid them

Mistakes in the management of carbohydrate intolerance and how to avoid them

Johann Hammer Johann Hammer, Heinz Florian Hammer, Mark Fox

Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update

Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update

Andrew Veitch Andrew Veitch

UEG Mistakes In Articles
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Mistakes in the management of carbohydrate intolerance and how to avoid them

Johann Hammer, Heinz Florian Hammer, Mark Fox

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

References

Mistakes
References
Mistake 1 Mistake 2 Mistake 3 Mistake 4 Mistake 5 Mistake 6 Mistake 7 Mistake 8
1.
Gallego D, Malagelada C, Accarino A, et al. Functional neuromuscular impairment in severe intestinal dysmotility. Neurogastroenterol Motil 2018; 30: e13458. [Link]
2.
Rosen R, Garza JM, Tipnis N, et al. An ANMS-NASPGHAN consensus document on esophageal and antroduodenal manometry in children. Neurogastroenterol Motil 2018; 30: e13239. [Link]
3.
Stanghellini V, Cogliandro RF, De Giorgio R, et al. Natural history of chronic idiopathic intestinal pseudo-obstruction in adults: a single center study. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 2005; 3: 449–458. [Link]
4.
Keller J, Bassotti G, Clarke J, et al. Expert consensus document: Advances in the diagnosis and classification of gastric and intestinal motility disorders. Nat Rev Gastroenterol Hepatol 2018; 15: 291–308. [Link]
5.
Ang D, Pannemans J, Vanuytsel T, et al. A single-center audit of the indications and clinical impact of prolonged ambulatory small intestinal manometry. Neurogastroenterol Motil 2018; 30: e13357. [Link]
6.
Alcalá-González LG, Malagelada C, Monrroy H, et al. Clinical significance of small bowel manometry patterns suggestive of intestinal obstruction. Neurogastroenterol Motil 2023; 35: e14462. [Link]
7.
Alcala-Gonzalez LG, Malagelada C, Galan C, et al. Propagation patterns of jejunal motor activity measured by high-resolution water-perfused manometry. Neurogastroenterol Motil Off J Eur Gastrointest Motil Soc 2021; 33: e14240. [Link]
8.
de Jonge CS, Smout AJPM, Nederveen AJ, et al. Evaluation of gastrointestinal motility with MRI: Advances, challenges and opportunities. Neurogastroenterol Motil 2018; 30: e13257. [Link]
9.
Maurer AH. Enhancing Scintigraphy for Evaluation of Gastric, Small Bowel, and Colonic Motility. Gastroenterol Clin North Am 2020; 49: 499–517. [Link]
10.
Ohkubo H, Kessoku T, Fuyuki A, et al. Assessment of small bowel motility in patients with chronic intestinal pseudo-obstruction using cine-MRI. Am J Gastroenterol 2013; 108: 1130–1139. [Link]
11.
Menys A, Butt S, Emmanuel A, et al. Comparative quantitative assessment of global small bowel motility using magnetic resonance imaging in chronic intestinal pseudo-obstruction and healthy controls. Neurogastroenterol Motil 2016; 28: 376–383. [Link]
12.
Alcalá-González LG, Accarino A, Martí R, et al. Distinctive gastrointestinal motor dysfunction in patients with MNGIE. Neurogastroenterol Motil 2023; 35: e14643. [Link]
13.
Alcalá González LG, Malagelada C. Current insights on chronic intestinal dysmotility: pseudo-obstruction and enteric dysmotility. Rev Esp Enferm Dig 2024; 116: 63–67. [Link]
14.
Di Nardo G, Zenzeri L, Guarino M, et al. Pharmacological and nutritional therapy of children and adults with chronic intestinal pseudo-obstruction. Expert Rev Gastroenterol Hepatol 2023; 17: 325–341. [Link]
15.
Basilisco G, Marchi M, Coletta M. Chronic intestinal pseudo-obstruction in adults: A practical guide to identify patient subgroups that are suitable for more specific treatments. Neurogastroenterol Motil 2024; 36: e14715. [Link]
16.
Bianco F, Lattanzio G, Lorenzini L, et al. Enteric Neuromyopathies: Highlights on Genetic Mechanisms Underlying Chronic Intestinal Pseudo-Obstruction. Biomolecules 2022; 12: 1849. [Link]
17.
Hahn JW, Moon SY, Kim MS, et al. ACTG2 Variants in Pediatric Chronic Intestinal Pseudo-obstruction With Megacystis. J Neurogastroenterol Motil 2022; 28: 104–110. [Link]
18.
Bianco F, Bonora E, Lattanzio G, et al. Clinical and Pathological Features of Severe Gut Dysmotility. Adv Exp Med Biol 2022; 1383: 9–17. [Link]
19.
D’Angelo R, Boschetti E, Amore G, et al. Liver transplantation in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical long-term follow-up and pathogenic implications. J Neurol 2020; 267: 3702–3710. [Link]
20.
Stanghellini V, Cogliandro RF, de Giorgio R, et al. Chronic intestinal pseudo-obstruction: manifestations, natural history and management. Neurogastroenterol Motil 2007; 19: 440–452. [Link]
21.
Knowles CH, Veress B, Tornblom H, et al. Safety and diagnostic yield of laparoscopically assisted full-thickness bowel biospy. Neurogastroenterol Motil 2008; 20: 774–779. [Link]
22.
Malagelada C, Karunaratne TB, Accarino A, et al. Comparison between small bowel manometric patterns and full-thickness biopsy histopathology in severe intestinal dysmotility. Neurogastroenterol Motil 2018; 30: e13219. [Link]
23.
De Giorgio R, Bianco F, Latorre R, et al. Enteric neuropathies: Yesterday, Today and Tomorrow. Adv Exp Med Biol 2016; 891: 123–133. [Link]
24.
De Giorgio R, Barbara G, Stanghellini V, et al. Clinical and morphofunctional features of idiopathic myenteric ganglionitis underlying severe intestinal motor dysfunction: a study of three cases. Am J Gastroenterol 2002; 97: 2454–2459. [Link]
25.
Rossi S, Merli E, Rinaldi R, et al. Paraneoplastic vs. non-paraneoplastic anti-Hu associated dysmotility: a case series and literature review. J Neurol 2022; 269: 1182–1194. [Link]
26.
Di Nardo G, Di Lorenzo C, Lauro A, et al. Chronic intestinal pseudo-obstruction in children and adults: diagnosis and therapeutic options. Neurogastroenterol Motil 2017; 29: e12945. [Link]
27.
Radocchia G, Neroni B, Marazzato M, et al. Chronic Intestinal Pseudo-Obstruction: Is There a Connection with Gut Microbiota? Microorganisms 2021; 9: 2549. [Link]
28.
Bor S, Kalkan İH, Savarino E, et al. Prokinetics-safety and efficacy: The European Society of Neurogastroenterology and Motility/The American Neurogastroenterology and Motility Society expert review. Neurogastroenterol Motil 2024; 36: e14774. [Link]
29.
Ohkubo H, Fuyuki A, Arimoto J, et al. Efficacy of percutaneous endoscopic gastro-jejunostomy (PEG-J) decompression therapy for patients with chronic intestinal pseudo-obstruction (CIPO). Neurogastroenterol Motil 2017; 29: e13127. [Link]
30.
Mann SD, Debinski HS, Kamm MA. Clinical characteristics of chronic idiopathic intestinal pseudo-obstruction in adults. Gut 1997; 41: 675–681. [Link]
31.
Emmanuel AV, Shand AG, Kamm MA. Erythromycin for the treatment of chronic intestinal pseudo-obstruction: description of six cases with a positive response. Aliment Pharmacol Ther 2004; 19: 687–694. [Link]
32.
O’Dea CJ, Brookes JH, Wattchow DA. The efficacy of treatment of patients with severe constipation or recurrent pseudo-obstruction with pyridostigmine. Colorectal Dis Off J Assoc Coloproctology G B Irel 2010; 12: 540–548. [Link]
33.
Sabbagh C, Amiot A, Maggiori L, et al. Non-transplantation surgical approach for chronic intestinal pseudo-obstruction: analysis of 63 adult consecutive cases. Neurogastroenterol Motil 2013; 25: e680-686. [Link]
34.
Sogawa H, Costa G, Armanyous S, et al. Twenty Years of Gut Transplantation for Chronic Intestinal Pseudo-obstruction: Technical Innovation, Long-term Outcome, Quality of Life, and Disease Recurrence. Ann Surg 2021; 273: 325–333. [Link]

Abstract

Carbohydrates not absorbed in the small intestine are fermented by colonic bacteria to organic acids and gases(e.g. carbon dioxide, hydrogen and methane), part of which is absorbed in the colon, the other part remaining in the lumen. Large interindividual differences have been demonstrated for the production of such acids and gas. Carbohydrate malabsorption can be diagnosed by using the hydrogen breath test, because the gases produced after administration of a provocative dose of carbohydrate are unique products of bacterial carbohydrate fermentation.

Topics

Small Intestine & Nutrition

Citation

Hammer HF, Hammer J and Fox M. Mistakes in the management of carbohydrate intolerance and how to avoid them. UEG Education 2019; 19: 9–14

Published

2019

More Like This:

MASLD with Sven Francque - Part 2

MASLD with Sven Francque - Part 2

Pradeep Mundre Pradeep Mundre, Sven Francque

Mistakes in the management of peritoneal malignancies and how to avoid them

Mistakes in the management of peritoneal malignancies and how to avoid them

Charlotte Rabl Charlotte Rabl, Tarkan Jäger, Andrea Barberis, Matteo Santoliquido, Francesco Saverio Papadia

Mistakes in ostomy management and how to avoid them

Mistakes in ostomy management and how to avoid them

Ian White Ian White, Iris Dotan, Revital Barkan

Mistakes in coeliac disease diagnosis and how to avoid them

Mistakes in coeliac disease diagnosis and how to avoid them

Roberto De Giorgio Roberto De Giorgio, Giacomo Caio, Umberto Volta

Mistakes in the management of carbohydrate intolerance and how to avoid them

Mistakes in the management of carbohydrate intolerance and how to avoid them

Johann Hammer Johann Hammer, Heinz Florian Hammer, Mark Fox

Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update

Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update

Andrew Veitch Andrew Veitch

UEG Standards and Guidelines
Clinical Practice Guideline
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update

Andrew Veitch

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Guideline

Abstract

This is a collaboration between the British Society of Gastroenterology (BSG) and the European Society of Gastrointestinal Endoscopy (ESGE), and is a scheduled update of their 2016 guideline on endoscopy in patients on antiplatelet or anticoagulant therapy. The guideline development committee included representatives from the British Society of Haematology, the British Cardiovascular Intervention Society, and two patient representatives from the charities Anticoagulation UK and Thrombosis UK, as well as gastroenterologists. The process conformed to AGREE II principles, and the quality of evidence and strength of recommendations were derived using GRADE methodology. Prior to submission for publication, consultation was made with all member societies of ESGE, including BSG. Evidence-based revisions have been made to the risk categories for endoscopic procedures, and to the categories for risks of thrombosis. In particular a more detailed risk analysis for atrial fibrillation has been employed, and the recommendations for direct oral anticoagulants have been strengthened in light of trial data published since the previous version. A section has been added on the management of patients presenting with acute GI haemorrhage. Important patient considerations are highlighted. Recommendations are based on the risk balance between thrombosis and haemorrhage in given situations.

Publisher

European Society of Gastrointestinal Endoscopy logo
European Society of Gastrointestinal Endoscopy

Guideline

Clinical Practice Guideline

Topics

Endoscopy

Citation

Endoscopy 2021; 53(09): 947-969

Published

2021

More Like This:

MASLD with Sven Francque - Part 2

MASLD with Sven Francque - Part 2

Pradeep Mundre Pradeep Mundre, Sven Francque

Mistakes in the management of peritoneal malignancies and how to avoid them

Mistakes in the management of peritoneal malignancies and how to avoid them

Charlotte Rabl Charlotte Rabl, Tarkan Jäger, Andrea Barberis, Matteo Santoliquido, Francesco Saverio Papadia

Mistakes in ostomy management and how to avoid them

Mistakes in ostomy management and how to avoid them

Ian White Ian White, Iris Dotan, Revital Barkan

Mistakes in coeliac disease diagnosis and how to avoid them

Mistakes in coeliac disease diagnosis and how to avoid them

Roberto De Giorgio Roberto De Giorgio, Giacomo Caio, Umberto Volta

Mistakes in the management of carbohydrate intolerance and how to avoid them

Mistakes in the management of carbohydrate intolerance and how to avoid them

Johann Hammer Johann Hammer, Heinz Florian Hammer, Mark Fox

Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update

Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update

Andrew Veitch Andrew Veitch

The global reference point for the digestive health community

Platform Publisher

United European Gastroenterology

Wickenburggasse 1 1080 Vienna, Austria

Contact us

support@ueg.eu

ueg.eu

T: +43 1 997 1639

Legal

Terms & Conditions

Imprint

Privacy Policy

Explore

My Bookmarks

My recommendations

My fields of interest

© 2026 United European Gastroenterology

Change fields of interest

These fields are selected based on the interests in your myUEG profile.
Click the item to unselect it. You can select multiple items.